Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

Basal-like breast cancer is an incurable disease with limited therapeutic options, mainly due to the frequent development of anti-cancer drug resistance. Therefore, identification of druggable targets to improve current therapies and overcome these resistances is a major goal. Targeting DNA repair m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Nieto-Jimenez, Cristina, Alcaraz-Sanabria, Ana, Martinez-Canales, Sandra, Corrales-Sanchez, Veronica, Montero, Juan Carlos, Burgos, Miguel, Nuncia-Cantarero, Miriam, Pandiella, Atanasio, Galan-Moya, Eva M., Ocaña, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7730833/
https://ncbi.nlm.nih.gov/pubmed/33261142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21239034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados